After participating in this learning activity, attendees should be able to:

• Describe the evolution of the treatment landscape for autoimmune and inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, psoriasis, and related disorders
• Assess the risks associated with untreated disease
• Demonstrate the importance of effective patient communication in achieving optimal outcomes
• Develop patient communication strategies for managing patients on JAK inhibitor therapy